Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy surveillance for uncomplicated falciparum malaria in Laos
ACTRN12618001572257Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria, sponsored by Ministry of Health. Primary endpoint: PCR-corrected treatment success rate. Started Apr 2017; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12618001572257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001572257.